Processa Pharmaceuticals, Inc.
PCSA
$2.55
-$0.01-0.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 364.79% | 118.17% | 24.51% | -67.52% | -74.69% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -80.53% | -86.68% | -90.13% | 0.37% | -25.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 201.77% | 36.14% | -4.34% | -61.66% | -66.64% |
|
|
|||||
| Total Current Assets | 201.77% | 36.14% | -4.34% | -61.66% | -66.64% |
| Net Property, Plant & Equipment | -94.98% | -95.84% | -75.57% | -62.20% | -49.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 67.84% | 17,967.27% | 18,067.27% | 18,067.27% | 23,070.91% |
| Total Assets | 141.96% | 53.47% | 7.64% | -51.64% | -44.19% |
|
|
|||||
| Total Accounts Payable | 19.97% | 2.18% | -17.55% | 21.34% | 182.70% |
| Total Accrued Expenses | 103.82% | 148.01% | 149.94% | 46.20% | 295.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -72.53% | -44.59% | -12.68% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 45.92% | 43.62% | 33.70% | 26.94% | 109.77% |
|
|
|||||
| Total Current Liabilities | 45.92% | 43.62% | 33.70% | 26.94% | 109.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -99.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 45.87% | 43.36% | 31.53% | 20.88% | 92.24% |
|
|
|||||
| Common Stock & APIC | 19.55% | 17.00% | 14.83% | 7.56% | 10.61% |
| Retained Earnings | -15.55% | -15.31% | -15.88% | -15.31% | -15.72% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 228.81% | 56.78% | 1.39% | -60.30% | -66.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 228.81% | 56.78% | 1.39% | -60.30% | -66.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 228.81% | 56.78% | 1.39% | -60.30% | -66.00% |
|
|
|||||